Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSisli Hamidiye Etfal Training and Research Hospital

About this trial

This study aims to prospectively validate the GRADY prediction models, which use machine learning algorithms to estimate the risk of gram-negative bacteremia and sepsis in intensive care unit (ICU) patients based on routinely collected vital signs and laboratory data. Sepsis, a life-threatening condition associated with high ICU mortality, requires early diagnosis and treatment-yet current diagnostic methods relying on blood cultures are time-consuming. Existing scoring systems such as SOFA, SIRS, and NEWS2 often lack sufficient sensitivity and specificity in early sepsis detection. Unlike traditional tools, the GRADY models seek to provide earlier and more accurate risk stratification. This study will compare the clinical performance of GRADY models against standard scoring systems and explore their integration as early warning tools to support rapid intervention and improve outcomes in critical care.

Eligibility criteria

Qualifiers

Patients aged 18 years or older

ICU stay of 48 hours or longer

Patients from whom blood cultures were obtained during routine monitoring

Signed informed consent form

Disqualifiers

Patients younger than 18 years

ICU stay shorter than 48 hours

Patients without blood cultures

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Sisli etfal research and training hospitalRecruiting34371, Seyrantepe, IstanbulTurkey (Türkiye)